What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Cancer research, Pathology, Glioma, Astrocytoma and IDH1.
His research integrates issues of Immunohistochemistry, Mutation, ATRX, Loss of heterozygosity and Tumor suppressor gene in his study of Cancer research.
Andreas von Deimling combines subjects such as DNA methylation and Gene expression profiling with his study of Pathology.
His work deals with themes such as Histone, Methylation, Bioinformatics and Histopathology, which intersect with DNA methylation.
His Glioma study integrates concerns from other disciplines, such as Internal medicine, CD8 and Oncology.
His Oligodendroglioma research focuses on Molecular biology and how it relates to Mutant.
His most cited work include:
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (1542 citations)
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (1510 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Pathology, Glioma, DNA methylation and Internal medicine are his primary areas of study.
His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Tumor suppressor gene, Gene, Carcinogenesis and Loss of heterozygosity.
His Pathology study incorporates themes from Astrocytoma and Oligodendroglioma.
His work in Glioma addresses subjects such as IDH1, which are connected to disciplines such as Isocitrate dehydrogenase and Molecular biology.
His DNA methylation research incorporates themes from Methylation and Epigenetics.
His research in Internal medicine focuses on subjects like Oncology, which are connected to Temozolomide, Bioinformatics and Cancer.
He most often published in these fields:
- Cancer research (55.09%)
- Pathology (49.18%)
- Glioma (29.57%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (55.09%)
- DNA methylation (29.46%)
- Pathology (49.18%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, DNA methylation, Pathology, Internal medicine and Glioma.
His Cancer research study combines topics in areas such as Mutation, Epigenetics, Immune system and GLI2.
His research in DNA methylation intersects with topics in Astrocytoma, Methylation, CDKN2A and Copy-number variation.
His work on Pathology is being expanded to include thematically relevant topics such as Mutation.
The Internal medicine study combines topics in areas such as Glioblastoma, Oncology and MEDLINE.
The study incorporates disciplines such as Cytotoxic T cell, Isocitrate dehydrogenase, Chemotherapy and Wild type in addition to Glioma.
Between 2019 and 2021, his most popular works were:
- cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
- cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. (83 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in DNA methylation, Pathology, Cancer research, Internal medicine and MEDLINE.
His DNA methylation research incorporates elements of Carcinogenesis, Astrocytoma, Pineoblastoma and Retinoblastoma.
He has included themes like Fusion gene and Methylation in his Pathology study.
His studies in Cancer research integrate themes in fields like Immune checkpoint, Papillary tumor and Immune system.
The concepts of his Internal medicine study are interwoven with issues in Oncology and Profiling.
His study in the field of Diffuse Glioma is also linked to topics like Kappa.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
